Report Detail
Global and China Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2020-2026
- RnM4198655 |
- 10 September, 2020 |
- Global |
- 127 Pages |
- QYResearch |
- Other
Global Alpha- Antitrypsin Deficiency Treatment Scope and Market Size
Alpha- Antitrypsin Deficiency Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alpha- Antitrypsin Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
CT-2009
POL-6014
ARO-AAT
ALNAAT-02
Others
Market segment by Application, split into
Clinic
Hospital
Others
Based on regional and country-level analysis, the Alpha- Antitrypsin Deficiency Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Alpha- Antitrypsin Deficiency Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Adverum Biotechnologies, Inc.
Alnylam Pharmaceuticals, Inc.
Applied Genetic Technologies Corporation
Arrowhead Pharmaceuticals, Inc.
Carolus Therapeutics, Inc.
Cevec Pharmaceuticals GmbH
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Editas Medicine, Inc.
Grifols, S.A.
Inhibrx
Intellia Therapeutics, Inc.
International Stem Cell Corporation
Ionis Pharmaceuticals, Inc.
Kamada Ltd.
Polyphor Ltd.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
Sangamo BioSciences, Inc.
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 CT-2009
- 1.2.3 POL-6014
- 1.2.4 ARO-AAT
- 1.2.5 ALNAAT-02
- 1.2.6 Others
- 1.3 Market by Application
- 1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application: 2020 VS 2026
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Perspective (2015-2026)
- 2.2 Global Alpha- Antitrypsin Deficiency Treatment Growth Trends by Regions
- 2.2.1 Alpha- Antitrypsin Deficiency Treatment Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Alpha- Antitrypsin Deficiency Treatment Historic Market Share by Regions (2015-2020)
- 2.2.3 Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Market Size
- 3.1.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Revenue (2015-2020)
- 3.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Players (2015-2020)
- 3.2 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Alpha- Antitrypsin Deficiency Treatment Revenue
- 3.4 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio
- 3.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Alpha- Antitrypsin Deficiency Treatment Revenue in 2019
- 3.5 Key Players Alpha- Antitrypsin Deficiency Treatment Area Served
- 3.6 Key Players Alpha- Antitrypsin Deficiency Treatment Product Solution and Service
- 3.7 Date of Enter into Alpha- Antitrypsin Deficiency Treatment Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Type (2015-2026)
- 4.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Type (2015-2020)
- 4.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Type (2021-2026)
5 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Application (2015-2026)
- 5.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Application (2015-2020)
- 5.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
- 6.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
- 6.3 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
- 6.4 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
- 7.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
- 7.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
- 7.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
- 8.2 China Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
- 8.3 China Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
- 8.4 China Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
- 9.2 Japan Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
- 9.3 Japan Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
- 9.4 Japan Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
- 10.2 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
- 10.3 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
- 10.4 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Adverum Biotechnologies, Inc.
- 11.1.1 Adverum Biotechnologies, Inc. Company Details
- 11.1.2 Adverum Biotechnologies, Inc. Business Overview
- 11.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.1.4 Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020))
- 11.1.5 Adverum Biotechnologies, Inc. Recent Development
- 11.2 Alnylam Pharmaceuticals, Inc.
- 11.2.1 Alnylam Pharmaceuticals, Inc. Company Details
- 11.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
- 11.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.2.4 Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 11.2.5 Alnylam Pharmaceuticals, Inc. Recent Development
- 11.3 Applied Genetic Technologies Corporation
- 11.3.1 Applied Genetic Technologies Corporation Company Details
- 11.3.2 Applied Genetic Technologies Corporation Business Overview
- 11.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.3.4 Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 11.3.5 Applied Genetic Technologies Corporation Recent Development
- 11.4 Arrowhead Pharmaceuticals, Inc.
- 11.4.1 Arrowhead Pharmaceuticals, Inc. Company Details
- 11.4.2 Arrowhead Pharmaceuticals, Inc. Business Overview
- 11.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.4.4 Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 11.4.5 Arrowhead Pharmaceuticals, Inc. Recent Development
- 11.5 Carolus Therapeutics, Inc.
- 11.5.1 Carolus Therapeutics, Inc. Company Details
- 11.5.2 Carolus Therapeutics, Inc. Business Overview
- 11.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.5.4 Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 11.5.5 Carolus Therapeutics, Inc. Recent Development
- 11.6 Cevec Pharmaceuticals GmbH
- 11.6.1 Cevec Pharmaceuticals GmbH Company Details
- 11.6.2 Cevec Pharmaceuticals GmbH Business Overview
- 11.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.6.4 Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 11.6.5 Cevec Pharmaceuticals GmbH Recent Development
- 11.7 Dicerna Pharmaceuticals, Inc.
- 11.7.1 Dicerna Pharmaceuticals, Inc. Company Details
- 11.7.2 Dicerna Pharmaceuticals, Inc. Business Overview
- 11.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.7.4 Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 11.7.5 Dicerna Pharmaceuticals, Inc. Recent Development
- 11.8 Digna Biotech, S.L.
- 11.8.1 Digna Biotech, S.L. Company Details
- 11.8.2 Digna Biotech, S.L. Business Overview
- 11.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.8.4 Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 11.8.5 Digna Biotech, S.L. Recent Development
- 11.9 Editas Medicine, Inc.
- 11.9.1 Editas Medicine, Inc. Company Details
- 11.9.2 Editas Medicine, Inc. Business Overview
- 11.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.9.4 Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 11.9.5 Editas Medicine, Inc. Recent Development
- 11.10 Grifols, S.A.
- 11.10.1 Grifols, S.A. Company Details
- 11.10.2 Grifols, S.A. Business Overview
- 11.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Introduction
- 11.10.4 Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 11.10.5 Grifols, S.A. Recent Development
- 11.11 Inhibrx
- 10.11.1 Inhibrx Company Details
- 10.11.2 Inhibrx Business Overview
- 10.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Introduction
- 10.11.4 Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 10.11.5 Inhibrx Recent Development
- 11.12 Intellia Therapeutics, Inc.
- 10.12.1 Intellia Therapeutics, Inc. Company Details
- 10.12.2 Intellia Therapeutics, Inc. Business Overview
- 10.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 10.12.4 Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 10.12.5 Intellia Therapeutics, Inc. Recent Development
- 11.13 International Stem Cell Corporation
- 10.13.1 International Stem Cell Corporation Company Details
- 10.13.2 International Stem Cell Corporation Business Overview
- 10.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
- 10.13.4 International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 10.13.5 International Stem Cell Corporation Recent Development
- 11.14 Ionis Pharmaceuticals, Inc.
- 10.14.1 Ionis Pharmaceuticals, Inc. Company Details
- 10.14.2 Ionis Pharmaceuticals, Inc. Business Overview
- 10.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 10.14.4 Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 10.14.5 Ionis Pharmaceuticals, Inc. Recent Development
- 11.15 Kamada Ltd.
- 10.15.1 Kamada Ltd. Company Details
- 10.15.2 Kamada Ltd. Business Overview
- 10.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
- 10.15.4 Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 10.15.5 Kamada Ltd. Recent Development
- 11.16 Polyphor Ltd.
- 10.16.1 Polyphor Ltd. Company Details
- 10.16.2 Polyphor Ltd. Business Overview
- 10.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
- 10.16.4 Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 10.16.5 Polyphor Ltd. Recent Development
- 11.17 ProMetic Life Sciences Inc.
- 10.17.1 ProMetic Life Sciences Inc. Company Details
- 10.17.2 ProMetic Life Sciences Inc. Business Overview
- 10.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 10.17.4 ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 10.17.5 ProMetic Life Sciences Inc. Recent Development
- 11.18 rEVO Biologics, Inc.
- 10.18.1 rEVO Biologics, Inc. Company Details
- 10.18.2 rEVO Biologics, Inc. Business Overview
- 10.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 10.18.4 rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 10.18.5 rEVO Biologics, Inc. Recent Development
- 11.19 Sangamo BioSciences, Inc.
- 10.19.1 Sangamo BioSciences, Inc. Company Details
- 10.19.2 Sangamo BioSciences, Inc. Business Overview
- 10.19.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
- 10.19.4 Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
- 10.19.5 Sangamo BioSciences, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Alpha- Antitrypsin Deficiency Treatment. Industry analysis & Market Report on Alpha- Antitrypsin Deficiency Treatment is a syndicated market report, published as Global and China Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Alpha- Antitrypsin Deficiency Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
